InvenireX

InvenireX is developing a nucleic acid detection platform that uses programmable DNA nanostructures captured within microfluidic chips, read by a proprietary AI-powered imaging system.

The technology detects genetic markers at concentrations below the threshold of conventional methods such as PCR, with potential to identify tumours earlier than current diagnostics.

Applications span early cancer detection and agricultural screening. The company builds on PhD research at Newcastle University and has raised £2 million in seed funding.